Jun Zhao

Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers

Alzheimer s & Dementia 2025cited by 7position: middledoi

Updated safety and efficacy data of combined KRAS G12C inhibitor (glecirasib, JAB-21822) and SHP2 inhibitor (JAB-3312) in patients with <i>KRAS p.G12C</i> mutated solid tumors.

Journal of Clinical Oncology 2024cited by 19position: firstdoi

Positive rate and quantification of amyloid pathology with [18F]florbetapir in the urban Chinese population

European Radiology 2023cited by 15position: middledoi

Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer (2022 edition)

Journal of the National Cancer Center 2023cited by 8position: middledoi

Comparison of [68Ga]Ga-FAPI and [18F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study

European Radiology 2022cited by 64position: middledoi

68Ga-FAPI-04 Versus 18F-FDG PET/CT in the Detection of Hepatocellular Carcinoma

Frontiers in Oncology 2021cited by 114position: middledoi

Comparison of [68 Ga]Ga-FAPI-04 and [18F]-FDG for the detection of primary and metastatic lesions in patients with gastric cancer: a bicentric retrospective study

European Journal of Nuclear Medicine and Molecular Imaging 2021cited by 100position: middledoi

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma

Frontiers in Oncology 2020cited by 2position: middledoi

No grants ingested yet.

Recent publications

Grants

Frequent collaborators